These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 6113285)

  • 41. beta 1-selective adrenoceptor antagonists. 1. Synthesis and beta-adrenergic blocking activity of a series of binary (aryloxy)propanolamines.
    Kierstead RW; Faraone A; Mennona F; Mullin J; Guthrie RW; Crowley H; Simko B; Blaber LC
    J Med Chem; 1983 Nov; 26(11):1561-9. PubMed ID: 6138434
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [p-[(Thienylcarbonyl)amino]phenoxy]propanolamines derivatives as diuretic and beta-adrenergic receptor blocking agents.
    Bouley E; Teulon JM; Cazes M; Cloarec A; Deghenghi R
    J Med Chem; 1986 Jan; 29(1):100-3. PubMed ID: 3001305
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Synthesis and adrenergic beta-blocking activity of some propanolamine derivatives.
    Obase H; Tatsuno H; Goto K; Shigenobu K; Kasuya Y; Yamada Y; Fujii K; Yada S
    Chem Pharm Bull (Tokyo); 1978 May; 26(5):1443-52. PubMed ID: 27307
    [No Abstract]   [Full Text] [Related]  

  • 44. [3-(3-Isopropylamino-2-hydroxypropoxy)estra-1,3,5(10)-trien-17-one].
    Da Re P; Valenti P; Braga PC; Ferri S
    Arch Pharm (Weinheim); 1975 Dec; 308(12):981-2. PubMed ID: 4050
    [No Abstract]   [Full Text] [Related]  

  • 45. 1-Alkylamino-3-(2-thiazolyloxy)-2-propanols. A novel class of mixed myocardial beta-stimulants-beta-blockers.
    Edwards JA; Berkoz B; Lewis GS; Halpern O; Fried JH; Strosberg AM; Miller LM; Urich S; Liu F; Roszkowski AP
    J Med Chem; 1974 Feb; 17(2):200-3. PubMed ID: 4148933
    [No Abstract]   [Full Text] [Related]  

  • 46. Synthesis and pharmacological activity of some 1-alkylamino-3-(2'-methoxy-4'-diethylcarbamoyl-phenoxy)propan-2-ols.
    Monforte P; Basile M; Previtera T; Larizza A; Marmo E; De Gennaro G; Montinaro C; Filippelli W; Montanaro CS; Marfella A; Larizza D
    Farmaco Sci; 1983 Mar; 28(3):173-86. PubMed ID: 6133779
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Beta-adrenergic blocking agents: substituted phenylalkanolamines. Effect of side-chain length on beta-blocking potency in vitro.
    Fuhrer W; Ostermayer F; Zimmermann M; Meier M; Müller H
    J Med Chem; 1984 Jul; 27(7):831-6. PubMed ID: 6145802
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [The beta-adrenolytic activity of new arylmethyloxypropanolamine analogs of dioxadilol].
    Baziard-Mouysset G; Ane-Margail M; Stigliani JL; Payard M; Verscheure Y; Tisne-Versailles J
    J Pharm Belg; 1994; 49(2):126-32. PubMed ID: 7913492
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Role of the (acyloxy)methyl moiety in eliciting the adrenergic beta-blocking activity of 3-(acyloxy)propanolamines.
    Macchia B; Balsamo A; Lapucci A; Macchia F; Martinelli A; Ammon HL; Prasad SM; Breschi MC; Ducci M; Martinotti E
    J Med Chem; 1987 Apr; 30(4):616-22. PubMed ID: 2882026
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Beta-Adrenergic blocking agents. 15. 1-Substituted ureidophenoxy-3-amino-2-propanols.
    Smith LH
    J Med Chem; 1977 May; 20(5):705-8. PubMed ID: 16137
    [No Abstract]   [Full Text] [Related]  

  • 51. Nondepressant beta-adrenergic blocking agents. 1. Substituted 3-amino-1-(5,6,7,8-tetrahydro-1-naphthoxy)-2-propanols.
    Condon ME; Cimarusti CM; Fox R; Narayanan VL; Reid J; Sundeen JE; Hauck FP
    J Med Chem; 1978 Sep; 21(9):913-22. PubMed ID: 31485
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [(Arylcarbonyl)oxy]propanolamines. 1. Novel beta-blockers with ultrashort duration of action.
    Kam ST; Matier WL; Mai KX; Barcelon-Yang C; Borgman RJ; O'Donnell JP; Stampfli HF; Sum CY; Anderson WG; Gorczynski RJ
    J Med Chem; 1984 Aug; 27(8):1007-16. PubMed ID: 6146718
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Synthesis and beta-adrenergic antagonist activity of novel (3-cyanodihydropyridyl)propanolamines.
    Vo D; Wolowyk MW; Knaus EE
    Drug Des Discov; 1991 Dec; 8(2):157-64. PubMed ID: 1686561
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Beta-adrenergic blocking agents of the flavone group. [(author's transl)]].
    Da Re P; Roveri P; Ferdenzi A; Murmann W
    Arch Pharm (Weinheim); 1975 Feb; 308(2):114-8. PubMed ID: 236740
    [No Abstract]   [Full Text] [Related]  

  • 55. Beta-adrenergic blockade by 3-[3-(substituted amino)-2-hydroxypropox]-5-hydroxybenzyl alcohols.
    Schwender CF; Pike RE; Shavel J
    J Med Chem; 1975 Feb; 18(2):211-3. PubMed ID: 235645
    [No Abstract]   [Full Text] [Related]  

  • 56. beta-Adrenergic blocking agents. 16. 1-(Acylaminomethyl-, ureidomethyl-, and ureidoethylphenoxy)-3-amino-2-propanols.
    Smith LH
    J Med Chem; 1977 Oct; 20(10):1254-8. PubMed ID: 20502
    [TBL] [Abstract][Full Text] [Related]  

  • 57. o-Chlorobenzenesulfonamidic derivatives of (aryloxy)propanolamines as beta-blocking/diuretic agents.
    Cecchetti V; Fravolini A; Schiaffella F; Tabarrini O; Bruni G; Segre G
    J Med Chem; 1993 Jan; 36(1):157-61. PubMed ID: 8093626
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Synthesis of a novel series of (aryloxy)propanolamines: new selective beta 2-blocking agents.
    Carre MC; Youlassani A; Caubere P; Saint-Aubin-Floch A; Blanc M; Advenier C
    J Med Chem; 1984 Jun; 27(6):792-9. PubMed ID: 6145801
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Synthesis and beta-adrenergic antagonist activity of heterocyclic propanolamines.
    Vo D; Wolowyk MW; Knaus EE
    Drug Des Discov; 1993 Jun; 10(2):89-99. PubMed ID: 8104518
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Studies on agents with vasodilator and beta-blocking activities. IV.
    Seki T; Nakao T; Masuda T; Hasumi K; Gotanda K; Ishimori T; Honma S; Minami N; Shibata K; Yasuda K
    Chem Pharm Bull (Tokyo); 1996 Nov; 44(11):2061-9. PubMed ID: 8945771
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.